| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | Oct 24, 2025 | Opus Genetics, Inc. | President | Sell | 26.3 | -23,795 | -6.94% | ✗ | $46.4K |
| Nov 21, 2024 | Nov 25, 2024 | Opus Genetics, Inc. | President | Buy | 82.5 | +10,000 | 3.00% | ✗ | $9.8K |
| May 15, 2024 | May 15, 2024 | Clearside Biomedical, Inc. | Director | Buy | 91.3 | +7,813 | 77.02% | ✗ | $10.2K |